Fosun International is emerging from a painful clean-up of its property portfolio with a sharper focus on pharmaceuticals, insurance and tourism, betting that years of asset sales and debt reduction have cleared the way for a return to growth.The group swung back to stronger profitability in the first half, helped by the absence of the heavy impairments that weighed on 2025 earnings.Chairman Guo Guangchang said in a statement on Thursday that the company had completed a systematic process of “repairing the roof on a sunny day”.“Over the past few years, Fosun has steadfastly advanced its business streamlining and core business-focused strategy,” Guo said. “Fosun has now returned to a growth trajectory and is well-positioned to accelerate its growth going forward.”The rebound comes after Fosun reported a 23.4 billion yuan (US$3.48 billion) loss in 2025, with property-related impairments accounting for about 55 per cent of the provisions.Fosun International chairman Guo Guangchang speaks at an event on June 29, 2026. Photo: HandoutThe group has since sold noncore and non-strategic assets to raise cash and reduce leverage, including more than 12 billion yuan of disposals in the first half of this year.